Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tramadol/promethazine - Charleston Laboratories

Next Previous
Drug Profile

Tramadol/promethazine - Charleston Laboratories

Alternative Names: CLP-417; Promethazine/tramadol

Latest Information Update: 28 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Charleston Laboratories
  • Class Antiemetics; Cyclohexanols; Dimethylamines; Opioid analgesics; Phenyl ethers; Propylamines; Sedating antihistamines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists; Muscarinic receptor antagonists; Opioid mu receptor agonists; Serotonin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Nausea and vomiting; Pain

Most Recent Events

  • 28 Sep 2021 No recent reports of development identified for phase-I development in Nausea and vomiting in USA (PO, Immediate release)
  • 28 Sep 2021 No recent reports of development identified for phase-I development in Pain in USA (PO, Controlled release)
  • 07 Aug 2018 Tramadol/promethazine - Charleston Laboratories is available for licensing in World as of 07 Aug 2018. https://charlestonlabs.com

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top